retifanlimab,pembrolizumab,Bria-IMT
Incyte,Merck,BriaCell Therapeutics
['briacell']
we appreciate bioquick news for picking up aacr news from 
CoreIR provides strategic investor and public relations services for small-mid cap companies. Experience the difference. #investorrelations #publicrelations